Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking Cessation 1Motor Activity 1Lung Neoplasms 1Inflammation 1

Interventions

Tobacco Use Cessation Devices 11Varenicline 8Surveys and Questionnaires 7Nicotine Replacement Therapy 7Standard of Care 6Motivational Interviewing 4Methods 4Ethanol 4Smoking Devices 3Videotape Recording 2Tobacco Products 2Secondary Prevention 2Preoperative Exercise 2Nicotine Chewing Gum 2Mindfulness 2Hematologic Tests 2Cognitive Behavioral Therapy 2Carbon Monoxide 2Bupropion 2Aspirin 2thiamine triphosphorate 1sulforaphane 1polyphenon E 1cytisine 1Yoga 1Urinalysis 1Transdermal Patch 1Transcranial Direct Current Stimulation 1Tomography, X-Ray Computed 1Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Smoking Cessation × cytisine × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡